Odutola, A., Owolabi, O., Owiafe, P., Mcshane, H., & Ota, M. (2012). A new TB vaccine, MVA85A, induces durable antigen-specific responses 14 months after vaccination in African infants.
Lua i Stíl Chicago (17ú heag.)Odutola, A., O. Owolabi, P. Owiafe, H. Mcshane, agus M. Ota. A New TB Vaccine, MVA85A, Induces Durable Antigen-specific Responses 14 Months After Vaccination in African Infants. 2012.
Lua MLA (9ú heag.)Odutola, A., et al. A New TB Vaccine, MVA85A, Induces Durable Antigen-specific Responses 14 Months After Vaccination in African Infants. 2012.
Rabhadh: Seans nach mbeach na luanna seo go hiomlán cruinn i ngach uile chás.